Balto Pharmaceuticals, Inc. — Form D

Balto Pharmaceuticals, Inc. of SOUTH PASADENA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-14. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2023-09-14
• Form: D
• Accession: 0001993350-23-000001
• Industry: Pharmaceuticals
• Exemptions: 04, 06b
• Total offering: $2.0M
• Amount sold: $2.0M
• Investors: 2
• Date of first sale: 2023-08-22
• Security types: equity
• Revenue range: Not Applicable
• SEC file number: 021-492095

Issuer

• Name: Balto Pharmaceuticals, Inc.
• CIK: 0001993350
• Entity type: Corporation
• Jurisdiction: CALIFORNIA
• Address: 99 PASADENA AVENUE, SOUTH PASADENA, CA, 91030
• Phone: 626-678-3368

Officers, directors & promoters (1)

More

• CIK 1993350 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search